Download PDF

Australian Organ and Tissue Donation and Transplantation Authority Amendment (New Governance Arrangements) Bill 2016

EML/Shutterstock.com

Posted 23/11/2016 by Philip Hamilton

Following the recommendations of a review conducted in 2015, the Australian Organ and Tissue

Donation and Transplantation Authority Amendment (New Governance Arrangements) Bill

2016 (the Bill) proposes that the current Australian Organ and Tissue Donation and

Transplantation Authority (OTA) Advisory Council be replaced by a governing Board that also

assumes many of the responsibilities currently assigned to the OTA’s Chief Executive Officer

(CEO). The Board would replace the CEO as the ‘accountable authority’ for the purposes of

the Public Governance, Performance and Accountability Act 2013 (PGPA Act). This appears to

be the first time a governing board, rather than an individual, has been the accountable authority

for a non-corporate Commonwealth Entity under the PGPA Act. In addition, the COAG Health

Council would acquire a role in the process for appointing Board members. However, the new

governance arrangements do not change the OTA’s functions. The Bill’s proposed

commencement date is 1 July 2017.

Reform of organ and tissue donation and transplantation

As outlined in a Bills Digest and a Research Paper published by the Parliamentary Library

in 2008, the Rudd Government introduced a suite of measures to institute a nationally consistent

and coordinated system of organ and tissue donation for transplantation. A key source of advice

was the National Clinical Taskforce on Organ and Tissue Donation initiated by the Howard

Government in 2006.

Reporting in early 2008, the Taskforce recommended the establishment of the OTA with a

governing board that was representative of clinicians, consumers, state-based organ donation

agencies, and ‘individuals with experience in business and public life’.

Establishment of the OTA

Rather than following the Taskforce’s proposal for a governing board, the Australian Organ and

Tissue Donation and Transplantation Authority Act 2008 (the Act) provided for the OTA’s CEO

to have the pre-eminent role in functions such as developing policy, declaring standards, and

making grants on behalf of the Commonwealth. The CEO is appointed by the responsible

Commonwealth Minister alone. The CEO is advised by an Advisory Council, whose 10 to 16

members are appointed by the Commonwealth Minister after consultation with relevant state and

territory ministers. In addition, the CEO can establish and make appointments to expert advisory

committees.

Review in 2015

In May 2015, the then Assistant Health Minister Fiona Nash observed that, despite significant

expenditure and some improvement since 2008, ‘organ transplant rates have not increased as

quickly as intended’. The Minister commissioned Ernst and Young (EY) to review the

implementation of the national reform agenda for organ and tissue donation, including the OTA.

Released in February 2016, the EY report found that ‘current governance arrangements are

advisory in nature and do not provide any strategic oversight, performance monitoring,

succession planning or mentoring of the CEO. The Review found that stakeholders were

generally in support of the establishment of a Board of governance for the OTA’. EY advised that

‘States and Territories will need to be involved in the selection of Board members with the Board

being skills-based, not representational.’

Proposed governance arrangements

The Bill generally reflects EY’s governance recommendations. A Board of eight members is

proposed (seven appointees, and the CEO ex officio).

The Bill requires that the Chair of the Board must have substantial experience in or knowledge of

public administration, business and/or management. EY’s recommendation that the Chair should

be ‘an experienced leader of public hospital organisations, but need not be a clinician’ has not

been included in the Bill, but has been adapted for the skill sets required of other Board members

(see below). The Bill does not require the Commonwealth Minister to consult state and territory

ministers on the appointment of the Chair. The Bill proposes that the Minister must consult the

Chair about the proposed appointment of a CEO.

Broadly consistent with EY’s recommendations on eligibility, the Bill proposes that appointees to

other positions on the Board must:

 have substantial experience in or knowledge of at least one of the following fields: public

hospital administration; consumer health issues; promotion of health issues; community

leadership or representation in relation to organ or tissue donation and transplantation

matters; any other appropriate field of expertise

 have substantial clinical expertise in organ or tissue donation or transplantation or

 be a consumer of health services.

The appointment processes proposed in the Bill are consistent with EY’s recommendations:

 before appointing a Deputy Chair, the Commonwealth Minister must request and consider

a written notice from each state and territory health minister nominating a person for

appointment and

 before appointing other Board members, the Commonwealth Minister must request and

consider a written notice from theCOAG Health Council nominating one or more persons

for appointment.

However, the Commonwealth Minister would not be obliged to follow the advice received from

state and territory ministers and the COAG Health Council.

EY estimated that the establishment of a Board would incur additional costs of about $200,000

per annum, mainly for payments to Board members. However, this additional cost would likely

be offset by the Bill’s proposed abolition of the Advisory Council, whose members are currently

remunerated.

The OTA is currently, and would continue to be, a listed entity under the Public Governance,

Performance and Accountability Act 2013 (PGPA Act).The Bill provides that the Board will

replace the CEO as the OTA’s accountable authority for the purposes of the PGPA Act. The

Minister’s second reading speech observed that ‘there are no existing non-corporate

Commonwealth Entities currently adopting this model’; that is, a model where the accountable

authority for a non-corporate Commonwealth Entity is a governing board rather than an

individual. Although unused to date, this arrangement is provided for in item 3 of subsection

12(2) of the PGPA Act.

The new governance arrangements do not change the OTA’s functions, but are expected to

improve the OTA’s performance in a highly complex area of health policy and service delivery.

Tags: accountability, public service reform, health system